Concourse Financial Group Securities’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10909 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 11191 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 11100 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10946 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10969 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 11104 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 11148 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 11231 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10851 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 11404 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 11432 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 11362 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 11248 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 10989 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 10439 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 9972 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 9379 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 8557 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7960 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7638 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7452 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7325 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7143 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7047 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6862 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6755 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6577 |
|